Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heavy metal containing doai
Patent
1998-05-22
1999-06-08
Fay, Zohreh
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heavy metal containing doai
514912, A61K 31295
Patent
active
059105100
ABSTRACT:
Photodynamic therapy of conditions of the eye, especially those conditions characterized by unwanted neovasculature, such as age-related macular degeneration, results in enhanced visual acuity for treated subjects.
REFERENCES:
Journal of Clinical Laser Medicine& Surgery, vol. 15, No. 1, p. 48 (1997): "QLT PhotoTherapeutics Enters Phase III Trial for Age-Related Macular Degeneration".
Schmidt-Erfurth, U. et al., Investigative Ophthalmologny& Visual Science, vol. 37, No. 3, p. 580 (1996): "Photodynamic Therapy of Subfoveal Choroidal Neovascularization Using Benzoporphyrin Derivative: First Results of a Multi-Center Trial".
Bunse, A. et al., Investigative Ophthalmology& Visual Science, vol. 37, No. 3, p. S223 (1996): "Photodynamic Therapy of Chorodal Neovascularization: Effects on Retinal Function Documented by Microperimetry".
Miller, J.W. et al., Archives of Ophthalmology, vol. 113, No. 6, pp. 810-818 (1995): "Photodynamic Therapy of Experimental Choroidal Neovasculariation Using Lipoprotein-Delivered Benzoporphyrin".
Young, L.H.Y. et al., Archives of Ophthalmology, vol. 114, No. 2, pp. 186-192 (1996): "Photodynamic Therapy of Pigmented Choroidal Melanomas Using a Liposomal Preparation of Benzoporphyrin Derivative".
Miller et al., Chemical Abstracts, 124:24930, 1995.
Schmidt-Erfurth, U. et al., "Photothrombosis of Ocular Neovasculariation Using Benzoporphyrin Derivative (BPD)," Abstract No. 2956, IOVS (1993) 34:1303.
Haimovici, R. et al., "Localization of Benzoporphyrin Derivative Monoacid in the Rabbit Eye,"Abstract No. 2955, IOVS (1993) 34:1303.
Walsh, A.W. et al., "Photodynamic Therapy of Experimental Choroidal Neovascularization Using Benzoporphyrin Derivative Monoacid," Abstract No. 2954, IOVS (1993) 34:1303.
Lin, S.C. et al, "Photodynamic Closure of Choroidal Vessels Using Benzoporphyrin Derivative," Abstract No. 2953, IOVS (1993)34:1303.
Moultan, R.S. et al., "Response of Retinal and Choroidal Vessels to Photodynamic Therapy Using Benzoporphyrin Derivative Monoacid," Abstract No. 2294, IOVS (1993) 34:1169.
Schmidt,U. et al., "Photosensitizing Potency of Benzoporphyrin Derivative (BPD) Associated with Human Low Density Lipoprotein (LDL)," Abstract No. 2802, IOVS (1992) 33:1253.
Fsadni Mario
Huber Gustav
Levy Julia
Strong H. Andrew
Fay Zohreh
QLT Phototherapeutics Inc
LandOfFree
Vision through photodynamic therapy of the eye does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vision through photodynamic therapy of the eye, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vision through photodynamic therapy of the eye will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1683511